13th October 2008 - New clinical trial

The Michael J. Fox Foundation is to carry out a clinical trial using the Nexalin Device. For more information go to The Michael J.Fox Foundation. Nexalin Therapy is a technology that uses a mild stimulation of the brain to treat a variety of mood disorders, specifically Anxiety, Depression, and Insomnia. The waveform of Nexalin is administered by placing medical grade conductive pads produced specifically for the Nexalin device on the forehead and behind each ear, which are connected to the Nexalin device with thin cables. The patient is placed in a reclining chair for the duration of a treatment session, which typically lasts for approximately forty minutes. For more information go to Nexalin Advanced Therapy. The disorders usually treated share a similar biochemistry with Parkinson's Disease. The intended effect appears to be like a milder version of DBS (Deep Brain Stimulation) but without using surgery as DBS does. In January 2008, a number of Parkinson's Disease patients carried out their own informal study. For more information go to ParkinsonsRebels.